How do you treat Candida krusei in a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida krusei in Urinary Tract Infections

For Candida krusei urinary tract infections, amphotericin B deoxycholate at a dose of 0.3-0.6 mg/kg daily for 1-7 days is the recommended first-line treatment. 1

Primary Treatment Approach

  1. Amphotericin B deoxycholate therapy:

    • Dosage: 0.3-0.6 mg/kg daily
    • Duration: 1-7 days
    • Strong recommendation with low-quality evidence 1
  2. Adjunctive measures:

    • Remove indwelling bladder catheter if present (strong recommendation) 1, 2
    • Eliminate urinary tract obstruction if present (strong recommendation) 1
    • Consider removal or replacement of nephrostomy tubes or stents if feasible 1
  3. Alternative local therapy option:

    • Amphotericin B deoxycholate bladder irrigation (50 mg/L sterile water daily for 5 days) may be useful for refractory cystitis 1, 2
    • If nephrostomy tubes are present, irrigation with amphotericin B (25-50 mg in 200-500 mL sterile water) is recommended 1

Special Considerations

Why fluconazole is not an option:

C. krusei exhibits intrinsic resistance to fluconazole, making this common antifungal ineffective 3, 4.

Limitations of other antifungals:

  • Echinocandins (e.g., caspofungin, micafungin) and newer azoles (voriconazole, posaconazole) generally achieve poor urinary concentrations and are not recommended for uncomplicated fungal UTIs 2, 4
  • However, in complex cases with tissue invasion or in transplant recipients where amphotericin B is contraindicated due to toxicity concerns, higher-dose echinocandins may be considered as demonstrated in case reports 3

Treatment approach based on infection severity:

  1. For asymptomatic candiduria:

    • Treatment is NOT recommended unless the patient belongs to a high-risk group 1, 2
    • High-risk groups requiring treatment include:
      • Neutropenic patients
      • Very low-birth-weight infants (<1500g)
      • Patients undergoing urologic manipulation
  2. For symptomatic cystitis:

    • Amphotericin B deoxycholate as outlined above 1
  3. For pyelonephritis:

    • Same treatment as cystitis with focus on eliminating obstruction 1
  4. For fungal balls or abscesses:

    • Surgical intervention is strongly recommended in addition to antifungal therapy 1, 2

Common Pitfalls to Avoid

  1. Using fluconazole for C. krusei infections (intrinsic resistance)
  2. Failing to remove indwelling catheters when feasible
  3. Not addressing underlying urinary tract obstruction
  4. Using antifungals with poor urinary concentrations (echinocandins, newer azoles) as primary therapy
  5. Treating asymptomatic candiduria in low-risk patients
  6. Not distinguishing between colonization and true infection

Monitoring and Follow-up

  • Assess clinical improvement of symptoms
  • Obtain follow-up urine cultures to confirm eradication
  • Continue treatment until symptoms resolve and cultures become negative
  • Consider surgical intervention for persistent infections or fungal balls

In refractory cases or patients with contraindications to amphotericin B, consultation with infectious disease specialists is warranted to consider alternative approaches such as higher-dose echinocandins in special circumstances 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fungal Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.